BDSX Biodesix, Inc.

Fundamentals / CIK 0001439725 / USD

Biodesix, Inc. reported $105.2M in revenue and a net loss of $27.08M for the trailing twelve months ended September 30, 2026 (up 10.4% year over year), with a -18.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BDSX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$94.14M$47.07M$0-$68.72MFY 2019 Revenue: $24.55MFY 2019 Net Income: -$30.73M2019FY 2020 Revenue: $45.56MFY 2020 Net Income: -$65.45M2020FY 2021 Revenue: $54.51MFY 2021 Net Income: -$43.16M2021FY 2022 Revenue: $38.21MFY 2022 Net Income: -$65.45M2022FY 2023 Revenue: $49.09MFY 2023 Net Income: -$52.15M2023FY 2024 Revenue: $71.32MFY 2024 Net Income: -$42.93M2024FY 2025 Revenue: $88.50MFY 2025 Net Income: -$35.27M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $88.50M $71.32M $49.09M $38.21M $54.51M $45.56M $24.55M
Research & Development $12.00M $9.56M $9.99M $13.10M $12.79M $10.82M $10.47M
Selling, General & Admin $87.55M $80.45M $67.39M $61.46M $50.52M $34.86M $30.64M
Total Operating Expenses $116.4M $105.8M $90.43M $88.80M $95.45M $68.49M $51.29M
Operating Income -$27.87M -$34.50M -$41.34M -$50.59M -$40.94M -$22.93M -$26.74M
EBITDA -$22.20M -$28.73M -$38.01M -$46.99M -$37.76M -$20.03M -$23.95M
Interest Income -- -- -- -- -- $18K $55K
Interest Expense $7.72M $8.26M $9.54M $8.07M $4.51M $7.60M $3.01M
Income Tax Expense $0 $0 $0 $0 $0 $0 --
Net Income -$35.27M -$42.93M -$52.15M -$65.45M -$43.16M -$65.45M -$30.73M
Basic EPS -$4.67 -$6.64 -$12.80 -$31.00 -$31.60 -$129.60 -$2,539.40
Diluted EPS -$4.67 -$6.64 -$12.80 -$31.00 -$31.60 -$129.60 -$2,539.40
Basic Shares Outstanding 7.6M 6.5M 4.1M 2.1M 1.4M 241.9K 12.1K
Diluted Shares Outstanding 7.6M 6.5M 4.1M 2.1M 1.4M 241.9K 12.1K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $24.04M $26.86M $25.55M $28.75M $21.77M $20.02M $17.96M $20.43M
Research & Development $2.99M $3.13M $3.29M $2.87M $2.99M $3.27M $2.87M $2.41M
Selling, General & Admin $22.50M $24.28M $24.26M $22.97M $21.71M $22.41M $20.45M $20.22M
Total Operating Expenses $30.15M $32.25M $31.76M $30.72M $28.82M $29.74M $27.09M $27.08M
Operating Income -$6.11M -$5.39M -$6.20M -$1.97M -$7.05M -$9.72M -$9.14M -$6.65M
EBITDA -$4.71M -$4.00M -$4.80M -$580K -$5.64M -$8.28M -$7.70M -$5.20M
Interest Expense $2.00M $1.98M $1.98M $2.06M $2.07M $1.90M $1.69M $1.75M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$8.03M -$7.27M -$7.79M -$3.98M -$8.72M -$11.47M -$11.10M -$8.25M
Basic EPS -$0.75 -$0.71 -$0.81 -- -$1.16 -$1.56 -$1.52 --
Diluted EPS -$0.75 -$0.71 -$0.81 -- -$1.16 -$1.56 -$1.52 --
Basic Shares Outstanding 10.7M 10.3M 9.7M -- 7.5M 7.3M 7.3M --
Diluted Shares Outstanding 10.7M 10.3M 9.7M -- 7.5M 7.3M 7.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.99M $26.25M $26.28M $43.09M $32.71M $62.13M $5.29M
Cash & Short-Term Investments $18.99M $26.25M $26.28M $43.09M $32.71M $62.13M $5.29M
Accounts Receivable, Net $9.04M $8.60M $7.68M $5.07M $3.66M $15.30M $5.29M
Other Current Assets $4.50M $4.64M $5.72M $5.18M $7.25M $8.71M $2.12M
Total Current Assets $32.52M $39.48M $39.68M $53.33M $43.61M $86.14M $12.70M
Property, Plant & Equipment, Net $24.82M $27.83M $27.87M $5.85M $4.18M $3.18M $2.12M
Goodwill $15.03M $15.03M $15.03M $15.03M $15.03M $15.03M $15.03M
Intangible Assets $3.88M $5.87M $7.91M $9.80M $11.62M $13.26M $15.09M
Other Non-Current Assets $8.23M $7.26M $6.86M $5.92M $1.66M $3.46M $90K
Total Non-Current Assets $54.96M $57.76M $59.41M $39.57M $32.48M $34.93M $32.33M
Total Assets $87.48M $97.24M $99.10M $92.91M $76.10M $121.1M $45.03M
Accounts Payable $3.08M $2.19M $2.93M $1.69M $1.66M $8.96M $1.72M
Deferred Revenue (Current) $961K $678K $324K $962K $1.85M $3.53M $1.28M
Other Current Liabilities $992K $641K $293K $41K -- -- --
Total Current Liabilities $17.44M $14.32M $33.42M $22.84M $28.96M $32.12M $22.60M
Long-Term Debt $50.01M $40.03M $40.08M $30.13M $10.07M $28.08M --
Deferred Revenue (Non-Current) -- -- -- $400K -- -- --
Other Non-Current Liabilities $1.02M $815K $712K $558K $1.39M $1.92M $358K
Total Non-Current Liabilities $72.50M $62.05M $61.10M $49.46M $27.41M $47.78M $53.61M
Total Liabilities $89.94M $76.37M $94.52M $72.30M $56.37M $79.90M $76.21M
Total Debt (incl. Leases) $75.41M $65.57M $65.49M $36.92M $11.57M $28.08M --
Common Stock $8.0K $7.0K $96K $78K $31K $27K $1.0K
Retained Earnings -$497.8M -$462.5M -$419.6M -$367.4M -$302.0M -$258.8M -$227.5M
Total Stockholders' Equity -$2.46M $20.88M $4.58M $20.61M $19.73M $41.17M -$225.1M
Total Equity -$2.46M $20.88M $4.58M $20.61M $19.73M $41.17M -$225.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $28.41M $30.00M $25.57M $18.99M $16.60M $20.73M $17.60M $26.25M
Cash & Short-Term Investments $28.41M $30.00M $25.57M $18.99M $16.60M $20.73M $17.60M $26.25M
Accounts Receivable, Net $9.12M $9.11M $9.50M $9.04M $12.67M $7.45M $7.64M $8.60M
Other Current Assets $4.61M $4.46M $5.84M $4.50M $4.12M $4.27M $4.38M $4.64M
Total Current Assets $42.13M $43.56M $40.91M $32.52M $33.40M $32.45M $29.62M $39.48M
Property, Plant & Equipment, Net $23.62M $23.80M $24.19M $24.82M $25.46M $26.14M $26.97M $27.83M
Goodwill $15.03M $15.03M $15.03M $15.03M $15.03M $15.03M $15.03M $15.03M
Intangible Assets $2.53M $2.98M $3.45M $3.88M $4.38M $4.87M $5.36M $5.87M
Other Non-Current Assets $6.30M $6.41M $7.86M $8.23M $7.51M $7.15M $7.30M $7.26M
Total Non-Current Assets $51.81M $51.76M $53.73M $54.96M $55.32M $55.30M $56.62M $57.76M
Total Assets $93.94M $95.33M $94.64M $87.48M $88.72M $87.74M $86.24M $97.24M
Accounts Payable $2.63M $2.16M $3.65M $3.08M $3.62M $2.97M $2.92M $2.19M
Deferred Revenue (Current) $360K $205K $223K $961K $2.77M $617K $788K $678K
Other Current Liabilities $556K $906K $927K $992K $637K $638K $1.09M $641K
Total Current Liabilities $14.25M $15.29M $14.49M $17.44M $18.15M $15.16M $13.32M $14.32M
Long-Term Debt $50.00M $50.00M $50.00M $50.01M $50.01M $50.02M $40.02M $40.03M
Other Non-Current Liabilities $782K $704K $860K $1.02M $769K $549K $692K $815K
Total Non-Current Liabilities $71.02M $70.89M $71.02M $72.50M $72.29M $71.44M $61.87M $62.05M
Total Liabilities $85.27M $86.18M $85.50M $89.94M $90.44M $86.60M $75.18M $76.37M
Total Debt (incl. Leases) $75.29M $74.98M $75.12M $75.41M $75.82M $75.36M $65.59M $65.57M
Common Stock $11K $11K $10K $8.0K $8.0K $146K $146K $7.0K
Retained Earnings -$520.9M -$512.8M -$505.6M -$497.8M -$493.8M -$485.1M -$473.6M -$462.5M
Total Stockholders' Equity $8.68M $9.14M $9.13M -$2.46M -$1.72M $1.14M $11.06M $20.88M
Total Equity $8.68M $9.14M $9.13M -$2.46M -$1.72M $1.14M $11.06M $20.88M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$35.27M -$42.93M -$52.15M -$65.45M -$43.16M -$31.35M -$30.73M
Depreciation & Amortization $5.67M $5.77M $3.33M $3.60M $3.18M $2.90M $2.79M
Stock-Based Compensation $4.14M $6.64M $5.37M $5.96M $4.94M $3.71M $170K
Change in Receivables -$531K -$1.81M -$4.72M -$1.50M $11.45M -$10.31M -$3.65M
Operating Cash Flow -$23.27M -$48.65M -$22.87M -$44.97M -$28.22M -$21.37M -$21.73M
Capital Expenditure -$259K -$3.23M -$22.92M -$3.30M -$2.24M -$1.95M -$1.31M
Free Cash Flow -$23.53M -$51.88M -$45.79M -$48.27M -$30.46M -$23.31M -$23.04M
Investing Cash Flow -$403K -$3.44M -$23.06M -$3.53M -$2.55M -$2.93M -$1.87M
Common Stock Issued $7.32M $55.62M $28.13M $59.54M $16.34M -- --
Financing Cash Flow $16.42M $52.05M $29.13M $58.88M $1.26M $81.13M $22.97M
Net Change in Cash -$7.26M -$39K -$16.80M $10.38M -$29.51M $56.84M -$626K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$8.03M -$7.27M -$7.79M -$3.98M -$8.72M -$11.47M -$11.10M -$8.25M
Depreciation & Amortization $1.40M $1.39M $1.40M $1.39M $1.41M $1.44M $1.44M $1.45M
Stock-Based Compensation $852K $820K $1.11M $1.07M $1.05M $1.04M $972K $1.26M
Change in Receivables -$200K $294K -$488K $3.61M -$5.22M $181K $904K -$1.00M
Operating Cash Flow -$7.20M -$1.56M -$10.17M $778K -$8.88M -$6.57M -$8.60M -$4.10M
Capital Expenditure -$555K -$197K -$81K -$86K -$48K -$51K -$74K -$839K
Free Cash Flow -$7.76M -$1.76M -$10.25M $692K -$8.93M -$6.62M -$8.68M -$4.93M
Investing Cash Flow -$600K -$254K -$144K -$104K -$67K -$95K -$137K -$884K
Common Stock Issued $6.56M $6.67M $17.21M -- -- -- -- $0
Financing Cash Flow $6.22M $6.24M $16.90M $1.71M $4.82M $9.79M $97K -$181K
Net Change in Cash -$1.59M $4.42M $6.58M $2.38M -$4.12M $3.13M -$8.64M -$5.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -31.5% -48.4% -84.2% -132.4% -75.1% -50.3% -108.9%
Net Profit Margin -39.8% -60.2% -106.2% -171.3% -79.2% -143.7% -125.1%
Return on Equity (ROE) -- -205.6% -1138.6% -317.6% -218.8% -159.0% --
Return on Assets (ROA) -40.3% -44.1% -52.6% -70.4% -56.7% -54.1% -68.2%
Current Ratio 1.86x 2.76x 1.19x 2.34x 1.51x 2.68x 0.56x
Quick Ratio 1.61x 2.43x 1.02x 2.11x 1.26x 2.41x 0.47x
Debt to Equity -- 3.14x 14.30x 1.79x 0.59x 0.68x --
Revenue Growth (YoY) +24.1% +45.3% +28.5% -29.9% +19.6% +85.6% --
5Y Revenue / Share Growth -93.8% -99.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -18.7% -20.0% -26.0% -31.5% -40.6% -44.5% -43.8% -48.4%
Net Profit Margin -25.7% -27.0% -33.3% -39.8% -49.3% -53.7% -54.3% -60.2%
Return on Equity (ROE) -312.1% -303.6% -349.9% -- -- -3609.7% -365.4% -205.6%
Return on Assets (ROA) -28.8% -29.1% -33.8% -40.3% -44.6% -46.8% -46.9% -44.1%
Current Ratio 2.96x 2.85x 2.82x 1.86x 1.84x 2.14x 2.22x 2.76x
Quick Ratio 2.63x 2.56x 2.42x 1.61x 1.61x 1.86x 1.90x 2.43x
Debt to Equity 8.68x 8.20x 8.23x -- -- 66.22x 5.93x 3.14x
Revenue Growth (YoY) +10.4% +34.2% +42.3% +40.8% +19.9% +11.7% +21.2% +39.3%
Source: SEC EDGAR CompanyFacts (CIK 0001439725) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:50 UTC · Open in terminal